Supernus Pharmaceuticals (SUPN) Deferred Taxes (2016 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Deferred Taxes of -$16.9 million for Q2 2026, down 136.65% year-over-year from $46.2 million in Q2 2025, and down 386.49% on a QoQ basis from $5.9 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Deferred Taxes (2016 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Deferred Taxes for 11 years, with the latest figure at -$16.9 million in Q2 2026.
- Deferred Taxes for Q2 2026 came in at -$16.9 million, down 136.65% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.3 million (up 130.1% YoY), and the FY2025 annual result was $5.2 million, up 125.85% from the prior year.
- Deferred Taxes eased to -$16.9 million in Q2 2026, from $5.9 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $19.0 million in Q4 2025 and troughed at -$16.9 million in Q2 2026.
- A 5-year average of -$4.3 million and a median of -$5.5 million in 2023 frame the typical range for Deferred Taxes.
- The widest annual swing landed in 2024, when Deferred Taxes sank 1160.23%; it then jumped 26493.06% in 2025.
- A 5-year view of Deferred Taxes shows it stood at -$7.8 million in 2022, then plunged by 34.78% to -$10.5 million in 2023, then surged by 99.31% to -$72000.0 in 2024, then jumped by 26493.06% to $19.0 million in 2025, then tumbled by 189.19% to -$16.9 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$16.9 million in Q2 2026, $5.9 million in Q1 2026, and $19.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | -16.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.95 Mn |
| Mar 31, 2026 | 5.92 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | -2.65 Mn |
| Jun 30, 2025 | -7.16 Mn |
| Mar 31, 2025 | -3.99 Mn |
| Dec 31, 2024 | -72,000.00 |
| Sep 30, 2024 | -6.47 Mn |
| Jun 30, 2024 | -8.12 Mn |
| Mar 31, 2024 | -5.48 Mn |
| Dec 31, 2023 | -10.46 Mn |
| Sep 30, 2023 | -9.27 Mn |
| Jun 30, 2023 | -5.55 Mn |
| Mar 31, 2023 | -435,000.00 |
| Dec 31, 2022 | -7.76 Mn |
| Sep 30, 2022 | -2.51 Mn |
| Jun 30, 2022 | -3.05 Mn |
| Mar 31, 2022 | -13.01 Mn |
| Dec 31, 2021 | -4.52 Mn |
| Sep 30, 2021 | 1.57 Mn |